• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Analyst Comment

Solar Foods: First Solein consumer product for sale in the United States

By Thomas WesterholmAnalyst
Solar Foods

Summary

  • Solar Foods has launched its first consumer product containing Solein protein in the United States, in collaboration with Ambrosia Collective, marking a significant step in its commercialization efforts.
  • Ambrosia Collective, a US-based sports nutrition company, is introducing a Solein-based protein powder under its Planta brand, initially available on its website and Amazon, with plans for nationwide expansion.
  • The US market is crucial for Solar Foods, and the launch serves as an important reference for Solein's suitability in the health and performance segment, aiding in brand awareness and risk reduction for future industrial-scale investments.
  • The analyst notes that the launch aligns with expectations and does not alter forecasts, as Ambrosia Collective's significant order was anticipated since January.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 6/3/2026 at 9:09 am EEST.

Solar Foods announced on Tuesday that the first consumer product containing the company's Solein protein has been launched in the United States. The launch is a collaboration with sports nutrition company Ambrosia Collective. We view the news as a positive step in the commercialization of Solein, as it demonstrates the product's suitability for the mainstream supplement market and serves as an important reference in the US market. The expected product launch does not cause changes to our forecasts, as we already knew about Ambrosia Collective's significant order in January.

Ambrosia Collective is a quality-focused partner in sports nutrition

US-based Ambrosia Collective is bringing a ready-to-mix protein powder made from Solein under its Planta brand to test marketing, which will be sold on the company's own website and on Amazon. The goal is to expand sales nationwide during the summer.

Ambrosia Collective is a medium-sized US-based supplement company founded in 2018. The company has established itself as a developer of high-quality, performance-enhancing, and vegan-friendly sports nutrition products. The company emphasizes clinically studied ingredients, transparent dosages, and independent testing in its products. Ambrosia has an extensive distribution network, including GNC, The Vitamin Shoppe, Sprouts, Amazon, and Hy-Vee. For example, The Vitamin Shoppe has over 600 stores in the United States, although we do not know exactly how widely the chain distributes Ambrosia Collective's products.

An important reference on the path towards industrial scale

The United States is a critical market for Solar Foods, and the company is commercializing Solein there, initially focusing on the health and performance segment. The launch now seen is the first consumer product made from Solein in the United States. While Solar Foods' revenue currently relies heavily on the limited capacity of the Factory 01 demonstration plant, these initial commercial launches are important for the investment story on the path to industrial scale. They build Solein's brand awareness and prove the raw material's functionality and suitability as part of partners' product development. Successful launches partly lower the company's risk profile as it seeks to convert letters of intent into binding sales agreements and raise financing for the industrial-scale Factory 02 investment, which is at the core of its investment story.

 

Login required

This content is only available for logged in users

Create account

Solar Foods established in 2017 is a global leader in sustainable protein production, solving the global food production problem by offering a completely new alternative to existing animal and plant proteins. Solar Foods’ first product is the naturally occurring single-cell protein Solein®, which can be used as a food raw material with high protein content. In the long run, Solein production will improve global availability of protein and increase price and quality stability of food raw materials by disconnecting food production from agriculture.

Read more on company page

Key Estimate Figures27.02.

202526e27e
Revenue0.11.94.3
growth-%560.1 %1,455.6 %125.7 %
EBIT (adj.)-10.4-12.7-19.9
EBIT-% (adj.)-8,414.9 %-660.1 %-459.7 %
EPS (adj.)-0.47-0.46-0.70
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

Here are Thomas’s comments as the Solein consumer product enters the U.S. market Solar Foods announced on Tuesday that the first consumer product...
6 hours ago
by Sijoittaja-alokas
1
Here are Thomas’s comments on Solar Foods’ partnership with Fortum Inderes – 15 May 26 Solar Foods: Fortum-kumppanuus madaltaa Factory 02:n ...
5/15/2026, 6:17 AM
by Sijoittaja-alokas
3
True, it requires documentation regarding toxicity, among other things, and that is of course how it should be. My post was partially unsuccessful...
5/9/2026, 4:43 AM
by Turska tai kuitti
1
Of course they want it and of course it has to be researched, since it is a novel food. It’s a completely standard thing.
5/9/2026, 2:51 AM
1
Did you look at the link I shared? I didn’t make up the toxicity part; EFSA wants to see documentation regarding, among other things, toxicity...
5/8/2026, 9:24 PM
by OsakasOssi
1
The word “toxicity” sounds a bit off to me, given that—at least on paper—solein is an excellent protein for human consumption (amino acids, ...
5/8/2026, 9:07 PM
by Turska tai kuitti
1
On top of this is the fact that no health authority in any significant market has yet approved the product, so the project might stall for that...
5/8/2026, 12:53 PM
by OsakasOssi
2